Eye Implant Helps Restore VIsion
A new system approved Thursday Feb. 14 by the Food and Drug Administration (FDA) may help patients who have lost sight regain some of their vision.
The new device is implanted inside of the eye and replaces damaged cells. The Argus II Retinal Prosthesis System is the first treatment for a rare genetic eye disorder that affects the retina membrane of the eye, causing it to deteriorate. The disease is called retinitis pigmentosa, causes the progression of the retina's photoreceptor cells and eventually leads to permanent blindness. These cells are necessary for the retina to capture and process light.
The device does not restore the patients' vision entirely but it may help them to perform daily tasks. Simple daily tasks such as walking on sidewalks and stepping onto curbs, recognizing words and sentences and matching different color socks becomes easier.
"It may allow them to detect light and dark in the environment," says the FDA. A study conducted in which 30 patients were given the implant resulted in them being able to better form daily tasks. Data reports that the disease affects about 100,000 people in the United States.
The FDA estimates that less than 4,000 patients will receive the device under the current approval requirements and regulations. Patients must be at least 25 years old and have advanced retinitis pigmentosa, showing little to no ability to detect light in both eyes. They should at least be able to make out shapes and forms and show signs of even faint remaining function of the retina.
Dr. Jeffrey Shuren, director for medical services at the FDA, said, "This new surgically implanted assistive device provides an option for patients who have lost their sight to RP — for whom there have been no FDA-approved treatments."
The National Institutes of Health, the National Science Foundation and the Department of Energy helped to fund the development of the Argus II by Second Sight Medical Products with $100 million in grants.
"Patients with retinitis pigmentosa in the United States for the first time ever will [now] have a treatment option," said Dr. Robert Greenberg, president and CEO of Second Sight Medical Products Inc.
President Trump Nominates Conservative Physician, Scott Gottlieb, To Head the FDA
President Donald Trump has nominated Dr. Scott Gottlieb as potential had of the US Food and Drug Administration (FDA) agency. Gottlieb is regarded as a conservative physician and businessman with extensive experience of how the pharmaceutical industry is run. In fact, many voices in the health industry call for the US Senate to approve his nomination for the job.
Nasal Irrigation Pots Increase Risk For Brain-Eating Amoebas
The FDA have issued a health warning to those who use nasal irrigation pots, or Neti pots, to make sure that they use distilled water, or even boil the water first, to avoid infections. The warning came after some reports of brain-eating amoeba surfaced not long ago during the flu season.
Researchers Create A Doomsday-Ready 'Liquid' Battery That Can Last For Over A Decade
Researchers at Harvard were able to create a "liquid" battery that is capable of providing energy for over 10 years.
FDA Approves Emflaza as Drug for Treating Muscular Dystrophy
The US Food and Drug Administration (FDA) has approved the use of deflazacort, marketed under the brand name Emflaza, for the treatment of Duchenne muscular dystrophy (DMD) in children. The steroid drug is manufactured by Marathon Pharmaceuticals and is the first to be so approved by the FDA to treat people with the condition in the United States.
Multiple Sclerosis Drug Can Cause Severe Liver Injuries, New Study Suggests
As the FDA starts to approve certain drugs, what’s the truth behind claims that MS drugs could potentially cause severe liver injuries? Is this the downside of Multiple Sclerosis drugs that we cannot truly evade? Here’s what health experts have to say.
FDA On Hyland's Teething Products With Poisonous Belladonna: Throw Them Out!
The FDA has found inconsistent amount of belladona in Hyland's teething products - some exceeding what's claimed on the label. Ever since the warning was first issued in 2010, the agency has been getting reports from parents sharing the adverse effects the products had on their children.
MORE IN ITECHPOST
Limited Edition Apple Watch NikeLab Are Now Available
According to Nike, the Apple Watch NikeLab is a limited edition and designed to be the "ultimate style companion" for runners.
'Tokyo Ghoul' Season 3 Delayed By Its Live-Action Movie? Ken Kenaki Returns With Another Identity?
"Tokyo Ghoul" season 3's release is delayed and there are countless speculations as to why it is being pushed back. Reports claim that the show is to give way to "One Punch Man" and "My Hero Acdemia" but new rumors say that it's lack of materials and storyline as well as its live-action movie are causing the delay.
Overwatch Update: Buggy D.Va Fixed, Game Reaches New Milestone
Well, looks like the fan-favorite D.Va is back in Overwatch. Check out the details here!